Table 2.
Approaches | Description | Advantages | Disadvantages |
---|---|---|---|
Prevalence | Frequency measure It evaluates all existing cases in a given period |
Ample results Specific policy planning Fast study and recommended for chronic diseases |
Considered weak at estimating the risk of developing disease |
Incidence | Frequency measure Assesses the number of new cases in a given period |
Implementation of measures to reduce new cases It is used more for acute diseases, since it estimates the risk of developing the disease |
Not recommended for chronic diseases |
Top-down | It measures the proportion of a disease attributed to several risk factors. It involves a study directed from total to lower levels | When the scope of study is well understood | More comprehensive, it hampers the study on the details of the disease |
Bottom-up | Related to the unit costs of inputs used. It involves the study directed from individual levels to the total. | More detailed | Risk of double counting |
Prospective | Temporal study, performed during disease. Probes the effect through the cause | Used in chronic diseases | Time-consuming and expensive |
Retrospective | Temporal study performed with preexisting data. Probes the cause through the effect |
Quick and cheaper | Risk of memory bias |
Econometric | Comparison of groups | Minor amount of data required Cost difference between the two populations |
Long study, requiring that the control group be paired to the study group |
Markov models | Stochastic process Used in prospective studies. Patients stratified in stages of disease |
Dynamic model aiming at studying the transition from one stage to another, evaluating the costs of each step | Transition of stages is independent, without considering the previous one |